Feedback / Questions
isomyosamine (MYMD-1) - MyMD Pharma, Akers Biosci
https://www.businesswire.com/news/home/20220222006271/en/MyMD-Pharmaceuticals-Enrolls-First-Patient-in-Phase-2-Clinical-Trial-of-MYMD-1-as-a-Therapy-for-Delaying-Aging-and-Extending-Healthy-Lifespan
Feb 23, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next